Annual CFI
$6.60 M
+$1.38 M+26.51%
December 1, 2023
Summary
- As of February 10, 2025, SKYE annual cash flow from investing activities is $6.60 million, with the most recent change of +$1.38 million (+26.51%) on December 1, 2023.
- During the last 3 years, SKYE annual CFI has risen by +$6.60 million (+91718.06%).
- SKYE annual CFI is now at all-time high.
Performance
SKYE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$1.45 M
-$1.41 M-4347.69%
September 1, 2024
Summary
- As of February 10, 2025, SKYE quarterly cash flow from investing activities is -$1.45 million, with the most recent change of -$1.41 million (-4347.69%) on September 1, 2024.
- Over the past year, SKYE quarterly CFI has dropped by -$2.59 million (-226.58%).
- SKYE quarterly CFI is now -125.51% below its all-time high of $5.67 million, reached on December 1, 2022.
Performance
SKYE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$343.00 K
-$2.52 M-115.77%
September 1, 2024
Summary
- As of February 10, 2025, SKYE TTM cash flow from investing activities is -$343.00 thousand, with the most recent change of -$2.52 million (-115.77%) on September 1, 2024.
- Over the past year, SKYE TTM CFI has dropped by -$2.55 million (-115.53%).
- SKYE TTM CFI is now -102.80% below its all-time high of $12.27 million, reached on September 1, 2023.
Performance
SKYE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SKYE Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.5% | -226.6% | -115.5% |
| 3 y3 years | +10000.0% | -294.8% | +32.2% |
| 5 y5 years | +10000.0% | -294.8% | +32.2% |
SKYE Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7356.9% | -125.5% | at low | -102.8% | +32.2% |
| 5 y | 5-year | at high | +7356.9% | -125.5% | at low | -102.8% | +32.2% |
| alltime | all time | at high | +7356.9% | -125.5% | at low | -102.8% | +32.2% |
Skye Bioscience Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.45 M(+4347.7%) | -$343.00 K(-115.8%) |
| Jun 2024 | - | -$32.50 K(-102.8%) | $2.18 M(-1.5%) |
| Mar 2024 | - | $1.14 M(<-9900.0%) | $2.21 M(-66.5%) |
| Dec 2023 | $6.60 M(+26.5%) | -$7000.00(-100.7%) | $6.60 M(-46.2%) |
| Sep 2023 | - | $1.07 M(>+9900.0%) | $12.27 M(+13.3%) |
| Jun 2023 | - | $0.00(-100.0%) | $10.83 M(+0.8%) |
| Mar 2023 | - | $5.53 M(-2.4%) | $10.75 M(+106.1%) |
| Dec 2022 | $5.21 M(-5836.4%) | $5.67 M(-1647.8%) | $5.21 M(-1130.3%) |
| Sep 2022 | - | -$366.10 K(+335.8%) | -$506.10 K(+203.6%) |
| Jun 2022 | - | -$84.00 K(+4100.0%) | -$166.70 K(+102.8%) |
| Mar 2022 | - | -$2000.00(-96.3%) | -$82.20 K(-9.6%) |
| Dec 2021 | -$90.90 K(+1162.5%) | -$54.00 K(+102.2%) | -$90.90 K(+106.1%) |
| Sep 2021 | - | -$26.70 K(-5440.0%) | -$44.10 K(+153.4%) |
| Jun 2021 | - | $500.00(-104.7%) | -$17.40 K(-2.8%) |
| Mar 2021 | - | -$10.70 K(+48.6%) | -$17.90 K(+148.6%) |
| Dec 2020 | -$7200.00(<-9900.0%) | -$7200.00(<-9900.0%) | -$7200.00(<-9900.0%) |
| Sep 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2019 | $0.00(-100.0%) | - | - |
| Dec 2018 | -$4400.00 | $0.00(0.0%) | -$4400.00(-81.7%) |
| Sep 2018 | - | $0.00(-100.0%) | -$24.10 K(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$3300.00(+200.0%) | -$24.10 K(+15.9%) |
| Mar 2018 | - | -$1100.00(-94.4%) | -$20.80 K(+5.6%) |
| Dec 2017 | -$19.70 K(+77.5%) | -$19.70 K(<-9900.0%) | -$19.70 K(<-9900.0%) |
| Sep 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2016 | -$11.10 K(+455.0%) | $0.00(0.0%) | -$11.10 K(0.0%) |
| Sep 2016 | - | $0.00(0.0%) | -$11.10 K(-15.3%) |
| Jun 2016 | - | $0.00(-100.0%) | -$13.10 K(0.0%) |
| Mar 2016 | - | -$11.10 K(<-9900.0%) | -$13.10 K(+555.0%) |
| Dec 2015 | -$2000.00(-91.4%) | $0.00(-100.0%) | -$2000.00(0.0%) |
| Sep 2015 | - | -$2000.00(<-9900.0%) | -$2000.00(<-9900.0%) |
| Jun 2015 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2015 | - | $0.00(-100.0%) | -$67.80 K(0.0%) |
| Dec 2014 | -$23.30 K(-38.8%) | - | - |
| Jul 2014 | - | -$67.80 K(<-9900.0%) | -$67.80 K(-716.4%) |
| Apr 2014 | - | $0.00(0.0%) | $11.00 K(+17.0%) |
| Jan 2014 | - | $0.00(0.0%) | $9400.00(-124.7%) |
| Oct 2013 | -$38.10 K(<-9900.0%) | $0.00(-100.0%) | -$38.10 K(0.0%) |
| Jul 2013 | - | $11.00 K(-787.5%) | -$38.10 K(-22.4%) |
| Apr 2013 | - | -$1600.00(-96.6%) | -$49.10 K(+3.4%) |
| Jan 2013 | - | -$47.50 K | -$47.50 K |
| Oct 2012 | $0.00 | - | - |
FAQ
- What is Skye Bioscience annual cash flow from investing activities?
- What is the all time high annual CFI for Skye Bioscience?
- What is Skye Bioscience annual CFI year-on-year change?
- What is Skye Bioscience quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Skye Bioscience?
- What is Skye Bioscience quarterly CFI year-on-year change?
- What is Skye Bioscience TTM cash flow from investing activities?
- What is the all time high TTM CFI for Skye Bioscience?
- What is Skye Bioscience TTM CFI year-on-year change?
What is Skye Bioscience annual cash flow from investing activities?
The current annual CFI of SKYE is $6.60 M
What is the all time high annual CFI for Skye Bioscience?
Skye Bioscience all-time high annual cash flow from investing activities is $6.60 M
What is Skye Bioscience annual CFI year-on-year change?
Over the past year, SKYE annual cash flow from investing activities has changed by +$1.38 M (+26.51%)
What is Skye Bioscience quarterly cash flow from investing activities?
The current quarterly CFI of SKYE is -$1.45 M
What is the all time high quarterly CFI for Skye Bioscience?
Skye Bioscience all-time high quarterly cash flow from investing activities is $5.67 M
What is Skye Bioscience quarterly CFI year-on-year change?
Over the past year, SKYE quarterly cash flow from investing activities has changed by -$2.59 M (-226.58%)
What is Skye Bioscience TTM cash flow from investing activities?
The current TTM CFI of SKYE is -$343.00 K
What is the all time high TTM CFI for Skye Bioscience?
Skye Bioscience all-time high TTM cash flow from investing activities is $12.27 M
What is Skye Bioscience TTM CFI year-on-year change?
Over the past year, SKYE TTM cash flow from investing activities has changed by -$2.55 M (-115.53%)